| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | nitisinone | FAERS: 55 | OFFSIDES US FAERS | |
| 2 | sapropterin | FAERS: 44 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 3 | Nitrous Oxide | FAERS: 5 | US FAERS | |
| 4 | glycerol phenylbutyrate | FAERS: 5 | US FAERS | |
| 5 | Cysteamine | FAERS: 4 | US FAERS | |
| 6 | Deferasirox | FAERS: 4 | US FAERS | |
| 7 | Fingolimod Hydrochloride | FAERS: 3 | US FAERS | |
| 8 | adefovir dipivoxil | FAERS: 3 | US FAERS | |
| 9 | 4-phenylbutyric acid | FAERS: 2 | US FAERS | |
| 10 | Acetaminophen | FAERS: 2 | US FAERS | |
| 11 | Lorcet | FAERS: 2 | US FAERS | |
| 12 | Metformin | FAERS: 2 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 13 | 17 alpha-Hydroxyprogesterone Caproate | FAERS: 1 | US FAERS | |
| 14 | Breo Ellipta | FAERS: 1 | US FAERS | |
| 15 | Buprenorphine | FAERS: 1 | US FAERS | |
| 16 | Duloxetine Hydrochloride | FAERS: 1 | US FAERS | |
| 17 | Ethosuximide | FAERS: 1 | US FAERS | |
| 18 | Gabapentin | FAERS: 1 | US FAERS | |
| 19 | Ondansetron | FAERS: 1 | US FAERS | |
| 20 | Pregabalin | FAERS: 1 | US FAERS | |
| 21 | Progesterone | FAERS: 1 | US FAERS | |
| 22 | Propranolol | FAERS: 1 | US FAERS | |
| 23 | Ranitidine | FAERS: 1 | US FAERS | |
| 24 | Ranitidine | FAERS: 1 | US FAERS | |
| 25 | Triumeq | FAERS: 1 | US FAERS | |
| 26 | Valproic Acid | FAERS: 1 | US FAERS | |
| 27 | Valsartan | FAERS: 1 | US FAERS | |
| 28 | acetaminophen, codeine drug combination | FAERS: 1 | US FAERS | |
| 29 | apremilast | FAERS: 1 | US FAERS | |
| 30 | Etoposide | OFFSIDES | ||
| 31 | Lenalidomide | OFFSIDES | ||
| 32 | Mitoxantrone | OFFSIDES | ||
| 33 | Sulfamethoxazole | OFFSIDES | ||
| 34 | Vigabatrin | OFFSIDES | ||
| 35 | sapropterin | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.